Tuesday, March 04, 2025 | 04:23 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: Short dose gap retained despite contrarian data

How concerned should the nation be about Covid variants, study shows high fatality risk after surgery done within 6 weeks of testing positive, and more-news relevant to India's fight against Covid-19

covid vaccine
Premium

FILE PHOTO: A healthcare worker using the vials of COVID-19 vaccine during the second phase of the COVID-19 vaccination at Rajiv Gandhi Super Speciality Hospital in New Delhi

Bharath Manjesh New Delhi
Covishield: Govt retains short dose gap despite research to the contrary

Despite results from a new analysis that indicate a longer gap between Covid-19 vaccine doses yields better clinical results, administrators in India reportedly prefer a shorter gap, a report in The Wire said. The analysis—published in the peer-reviewed medical journal The Lancet last month—found that Covishield’s efficacy is 55.1% when its two doses are given less than six weeks apart but 81.3% when administered 12 weeks apart. India is administering Covishield’s doses 28 days apart. The analysis concludes that increasing the gap also increases the vaccine’s immunogenicity—the ability of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in